|
Volumn 50, Issue 10, 2010, Pages 22-26
|
The efficacy and safety of the combination of β-blocker bisoprolol and If inhibitor ivabradine in patients with stable angina and chronic obstructive pulmonary disease
|
Author keywords
Angina pectoris; Bisoprolol; Chronic obstructive pulmonary disease; Ivabradine
|
Indexed keywords
BENZAZEPINE DERIVATIVE;
BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
BRONCHODILATING AGENT;
CYCLIC NUCLEOTIDE GATED CHANNEL;
IVABRADINE;
AGED;
ANGINA PECTORIS;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SCREENING;
FEMALE;
HEART RATE;
HOSPITAL READMISSION;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MONITORING;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS;
AGED;
ANGINA PECTORIS;
BENZAZEPINES;
BISOPROLOL;
BRONCHODILATOR AGENTS;
CYCLIC NUCLEOTIDE-GATED CATION CHANNELS;
DRUG DOSAGE CALCULATIONS;
DRUG EVALUATION;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
HEART RATE;
HUMANS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
PATIENT READMISSION;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
|
EID: 79955097006
PISSN: 00229040
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (8)
|